secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYNAVAX TECHNOLOGIES CORP (—)
CIK:        0001029142
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0000950170-24-039305
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dynavax appoints CEO Ryan Spencer as Interim CFO during CFO's maternity leave
-----------------------------------------------------------------------------

- CFO Kelly MacDonald begins maternity leave April 1, 2024; expected return in early August 2024.
- CEO Ryan Spencer appointed Interim CFO (principal financial officer) effective April 1, 2024.
- No change in Spencer's compensation for assuming additional CFO duties.
- Other officers assume some CFO duties; senior consultant with public company CFO experience hired.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024039305/0000950170-24-039305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024039305/dvax-20240329.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-039305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer